Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroids vs NSAIDs +/- Atorvastatin for TB-IRIS
NCT01442428Phase 3Withdrawn
- Sponsor
- University of Minnesota
- Start
- Jan 2014
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atorvastatin in tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS), sponsored by University of Minnesota. Planned start Jan 2014; status: withdrawn.
02
Drugs
atorvastatin
03
Conditions
tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS)
Beyond the preview
Go deeper on NCT01442428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01442428.